Neutralizing Interleukin (IL)-6

Clinical trial NCT07493317 · RECRUITING

Trial details

NCT number: NCT07493317
Sponsor: Icahn School of Medicine at Mount Sinai
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2026-03-26
Primary completion: 2031-02-06
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.